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Abstract: Chronic obstructive pulmonary disease (COPD) is an obstructive and progressive 
airway disease associated with an important reduction in daily physical activity and psychologi-
cal problems that contribute to the patient’s disability and poor health-related quality of life 
(HRQoL). Nowadays, pulmonary rehabilitation (PR) plays an essential role in the management 
of symptomatic patients with COPD, by breaking the vicious circle of dyspnea–decreased 
activity–deconditioning–isolation. Indeed the main benefits of comprehensive PR programs for 
patients with COPD include a decrease in symptoms (dyspnea and fatigue), improvements in 
exercise tolerance and HRQoL, reduction of health care utilization (particularly bed-days), as 
well as an increase in physical activity. Several randomized studies and meta-analyses greatly 
established the benefits of PR, which additionally, is recommended in a number of influential 
guidelines. This review aimed to highlight the impact of PR on COPD patients, focusing on the 
clinical usefulness of PR, which provides patients a good support for change.
Keywords: chronic obstructive pulmonary disease, exercise training, physical activity, quality 
of life
Introduction
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) is constantly 
increasing,1 while its incidence is growing in old age.2,3 COPD is also a leading cause 
of morbidity worldwide, particularly in developing countries.1 Whereas COPD is an 
obstructive and progressive airway disease, it is also associated with a significant 
reduction in physical activity, and psychological problems, all of which contribute 
to the patient’s disability and poor health-related quality of life (HRQoL).3 Recently, 
emphasis has been placed on questionnaires designed to assess health status and 
prognosis in COPD.4
For a long time, the treatment of COPD has focused mainly on pharmacological 
improvement of the airway obstruction. However over the last two decades, growing 
evidence of systemic manifestations in COPD patients and their negative effects on the 
functioning of these patients has accelerated the development and use of nonpharma-
cological treatments, such as pulmonary rehabilitation (PR). PR and pharmacological 
therapy are not competitive but rather, must work closely together, if they are to result 
in a more successful outcome. One particular study has shown that a better outcome 
(exercise tolerance) of PR can be obtained when it is associated with long-acting anti-
cholinergic bronchodilators.5 Moreover, PR has been shown to be the most effective 
nonpharmacological intervention for improving health status in COPD patients and 
has become a standard of care for COPD patients.3






































Figure 1 COPD’s “vicious” circle.
Abbreviation: COPD, chronic obstructive pulmonary disease.





Many PR programs have been developed and provided 
by multidisciplinary teams and typically include components 
such as patient assessment, exercise training, education, 
nutritional intervention, and psychosocial support.
The benefit of PR in patients with COPD in improving exer-
cise capacity and HRQoL, and in reducing breathlessness and 
health care utilization (particularly bed days) has been widely 
established by randomized studies, summarized in reviews, 
and by meta-analyses.6–10 PR is now recommended in several 
influential guidelines.3,11 Unfortunately the practical use of reha-
bilitation in COPD is virtually nonexistent or under-resourced 
in most countries. Misunderstanding on the usefulness of a PR 
program, in addition to the high cost has hindered the wide-
spread distribution of comprehensive PR centers.
This review aimed to present the use of PR in COPD 
and to highlight the impact of PR on patients with COPD, 
focusing on the clinical usefulness of PR, which provides 
patients a favorable environment for optimizing therapy. We 
also hoped to stimulate or persuade pulmonary physicians 
to use PR more often.
COPD: a systemic disease  
with effort limitation
For a long time, COPD was considered to be a respiratory 
disease, mainly caused by tobacco smoking and leading to 
progressive dyspnea. However, additionally, COPD pro-
duces inactivity, which promotes further loss of exercise 
capacity (deconditioning) through the loss of muscle mass, 
creating a “vicious” circle (Figure 1). Indeed, COPD has 
substantial manifestations beyond the lungs − the so-called 
systemic effects, such as unintentional weight loss and 
skeletal muscle dysfunction. The chronic systemic inflam-
mation that is linked to COPD may also initiate or exac-
erbate comorbid diseases, such as cardiovascular disease, 
osteoporosis, anemia, type 2 diabetes, lung cancer, and 
depression3,12,13 and is one of the key mechanisms underly-
ing these extrapulmonary effects.12–14 Consequently, COPD 
patients are disabled by the systemic manifestations of the 
disease, the most significant systemic dysfunction in COPD 
patients being the peripheral muscle dysfunction resulting 
from both physical inactivity and systemic inflammation,15,16 
to which we can add hypoxemia, undernutrition, oxidative 
stress, and systemic corticosteroid therapy.16 This peripheral 
muscle dysfunction is related to diverse pathophysiological 
changes in the skeletal muscle, namely reduced oxidative 
capacity with early lactic acidemia and oxidative stress,17–19 
decrease in the volume of muscular fibers,20 fiber type redis-
tribution (shift from type 1 to type 2 fibers),20–22 and altered 
capillarization of these fibers.22 These alterations lead to 
higher concentrations of lactate for a given work, which 
stimulate ventilation, provoking dynamic hyperinflation 
and increasing ventilatory burden. Moreover, they induce 
an increasing susceptibility to muscular fatigue and a too 
early termination of exercise. The limitation of activity also 
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promotes a sedentary lifestyle and the social isolation of 
COPD patients, with an increased risk of depression and 
anxiety, leading to further inactivity due to fear of breath-
lessness and consecutively further physical deconditioning. 
Exacerbations of COPD also promote the reduction of 
exercise performance, dyspnea, and the loss of HRQoL, 
accelerating the path of this vicious circle.23
In summary, inactivity leads to deconditioning, mainly 
caused by breathlessness. This breathlessness leads to an 
increased fear of exertion and an avoidance of physical and 
social activities, thrusting the patient into a vicious circle 
leading to further isolation and depression, accompanied by 
a reduced HRQoL (Figure 1).
What is pulmonary rehabilitation?
The updated statement by the American Thoracic Society and 
the European Respiratory Society (ATS/ERS) Task Force on 
PR gives the following definition of PR:
Pulmonary rehabilitation is a comprehensive intervention 
based on a thorough patient assessment followed by patient-
tailored therapies, which include, but are not limited to, 
exercise training, education and behavior change, designed 
to improve the physical and emotional condition of people 
with chronic respiratory disease and to promote the long-
term adherence of health-enhancing behaviors.24
This definition emphasizes that PR is a well-proven struc-
tured and multidisciplinary treatment approach including 
patient assessment, physical training and peripheral muscle 
strengthening, occupational therapy, education of the patient, 
smoking cessation intervention, nutritional intervention, and 
psychosocial support. PR thus establishes a personalized and 
global treatment for the symptomatic COPD patient. A PR 
program is not a stand-alone therapy, but rather, should be 
integrated into a management program in which the general 
practitioner as well as the patient’s pulmonary specialist take 
an active part. By using a holistic approach centered on the 
patient, PR aims to reverse the systemic manifestations of 
COPD as well as to relieve the fears and anxiety associated 
with social and exterior activities, thereby leading to a change 
in the patient’s day-to-day life. Finally, PR aims to break the 
aforementioned vicious circle in COPD (Figure 1).
Who should attend a pulmonary 
rehabilitation program?
PR offers benefits for all patients suffering from a chronic 
respiratory disease of whatever origin, who have a decrease 
of pulmonary function, who are symptomatic, and who have 
intolerance to effort, in spite of an optimal pharmacological 
treatment.6,8,9 Even candidates for lung volume reduction 
surgery for severe emphysema or for lung transplanta-
tion are good candidates for PR.25 A program of PR may 
be proposed in stable COPD as well as immediately 
after COPD exacerbation.26 In agreement with the joint 
statement of the ATS/ERS of 2006, all patients suffer-
ing from the systemic consequences of COPD are good 
candidates for PR.8 According to the new Global initiative 
for Obstructive Lung Disease (GOLD) guidelines, COPD 
patients (groups B−D) will benefit from a PR program.3 
However, a recent evidence-based practice guideline from 
the American College of Physicians supports the use of PR 
for symptomatic severe COPD patients (FEV
1
 ,50% of 
predicted: strong recommendation) and for symptomatic 
or exercise-limited patients with FEV
1
 $50% of predicted 
(weak recommendation).11
Usually COPD patients are referred to a PR center by 
their chest physician or directly by their general practitioner, 
after which the pneumologist, center manager, or one of the 
team assesses the appropriateness of the indication for a 
multidisciplinary PR program. If a home-based PR program 
is considered, a close coordination between the different 
care providers is essential, if possible, in a care network. 
However, the reimbursement of the PR costs in the various 
modalities depends on the financial situation of the patient 
and their social security, as well as the rules of each country’s 
particular health care system.
Contraindications and barriers  
to pulmonary rehabilitation
The main contraindications are lack of motivation and nonad-
herence, psychiatric illness or dementia, uncontrolled cardio-
vascular diseases, inability to do exercise (for orthopedic or 
other reasons), and unstable diseases (eg, hepatic, diabetes).6 
In some countries, active cigarette smoking is considered 
as a relative contraindication. While it has been proven that 
current smokers obtain the same benefits from PR, they will 
nevertheless be encouraged to undergo a smoking cessation 
program. However, the adherence to PR by smokers gener-
ally remains less than that of ex-smokers.27–29
Nevertheless, we believe that excluding smoking 
patients would deprive them of a potential opportunity to 
quit smoking.30 Age31 as well as the degree of the bron-
chial obstruction32,33 do not constitute contraindications to 
PR; neither does continuous or intermittent noninvasive 
ventilation. Exertional severe hypoxemia must be corrected 
beforehand, by oxygen therapy.
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Table 1 Main outcomes of pulmonary rehabilitation in COPD patients
Outcome Source Comments
Improvement of exercise  
performance
ACCP/AACvPR9 High evidence and strong recommendation (1A)†
ACP clinical practice guideline37 PR programs improve exercise capacity
Clinical practice guideline for physiotherapists35 Strong recommendation
GOLD3 evidence grade A‡
ACP systematic review39 No clinically significant improvement in the 6-minute  
walk distance#
Cochrane review7 Clinically insignificant improvement in the 6-minute walk 
distance
Meta-analysis38 No clinically significant improvement in the 6-minute 
walk distance
Dyspnea relief ACCP/AACvPR9 High evidence and strong recommendation (1A)
Cochrane review7 effect on the dyspnea domain of the CRQ§ was a greater 
than the minimum clinically important difference
GOLD3 evidence grade A
ACP systematic review39 Meta-analysis38 Average effect on the dyspnea domain of the CRQ was 
clinically significant
Improved health-related  
quality of life
ACCP/AACvPR9 High evidence and strong recommendation (1A)
ACP clinical practice guideline,37 ACP  
systematic review39
PR programs improve health status
GOLD3 evidence grade A
Clinical practice guideline for physiotherapists35 Strong recommendation
Cochrane review7 effect on all domains of the CRQ were greater than the 
minimum clinically important difference
Meta-analysis38 Pooled difference in health status scores on the SGRQ 
was clinically significant*
Notes: †Evidence comes from well-designed RCTs yielding consistent and directly applicable results: benefits clearly outweigh the risks and burdens; ‡GOLD RCTs: 
A = rich body of data; B = limited body of data; #clinically significant effect size of 53 meters or more; §for the CRQ health status questionnaire for COPD (with dyspnea, 
fatigue, emotion, and mastery domains), an increase of 0.5 points per item or 10 points for total score is considered to be clinically significant;77 *for the SGRQ health status 
questionnaire, a 4-unit reduction (out of 100) is defined as a clinically noticeable improvement.79
Abbreviations: ACCP/AACVPR, American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation; ACP, American College of 
Physicians; COPD, chronic obstructive pulmonary disease; CRQ, Chronic Respiratory Questionnaire; GOLD, Global initiative for Obstructive Lung Disease; PR, pulmonary, 
rehabilitation; RCT, randomized controlled trial; SGRQ, St George’s Respiratory Questionnaire; 1A, high evidence and strong recommendation.





Few studies have established the predictive factors of 
nonadherence to PR. However, besides active smoking, 
there is social isolation,29 depression, and lower quadri-
ceps strength.27 Furthermore, a retrospective analysis has 
shown that COPD patients are less likely to complete a 
PR program if they are current smokers, attend a long-
lasting program, have suffered frequent exacerbations 
requiring hospital admission in the preceding year, have a 
long journey time to reach the center, and higher Medical 
Research Council (MRC) dyspnea score.34 In a more recent 
review, Keating et al identified travel and transport, a lack 
of perceived benefit of PR, being current smoker, illness, 
and depression as barriers to completion of a PR program.28 
For such reasons, the dropout rate from PR reported in 
most of these studies was within the order of 20%−30%. 
The aforementioned reasons are often intercurrent ill-
nesses (severe exacerbations of COPD and COPD-related 
and non-COPD-related hospitalizations) and logistical 
problems (such as transport facilities, cost for the patient, 
and distance from the center).
Evidence of the effectiveness of  
pulmonary rehabilitation in COPD
Based on various published RCTs and on meta-analyses, 
numerous evidence-based reviews have evaluated the effect 
of PR programs on symptomatic COPD patients. These have 
demonstrated the effectiveness and utility of PR. The main 
outcomes, including exercise performance, dyspnea, HRQoL, 
psychosocial benefits, cost effectiveness, reduced health care 
utilization, and survival (Tables 1 and 2) have been reported. 
Some of these reviews and meta-analyses are summarized in 
Tables 1 and 2 along with some comments.3,7,9,26,35–39 The ben-
efits on many laboratory and clinical parameters associated 
with PR are produced without demonstrable improvements 
in pulmonary function. This apparent contradiction could be 
explained by the fact that we know that PR acts mainly on 
the systemic effects of the disease.
Among the multiple benefits of PR, we would like to 
examine the reduction of exacerbations, followed by the cost 
effectiveness. Indeed, a reduction in the use of the health 
care system is an important goal of PR because COPD 
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Table 2 Main outcomes of pulmonary rehabilitation in COPD patients
Outcome Source Comments
Psychosocial benefits ACCP/AACvPR9 Moderate evidence and weak recommendation (2B)
GOLD3 Reduced anxiety and depression; evidence grade A‡
Improvement of upper extremities  
performance
ACCP/AACvPR9 Unsupported endurance training of upper extremities:  
high evidence and strong recommendation (1A)†
GOLD3 Strength and endurance of the upper limbs improve arm 
function (evidence grade B)‡
Cost effectiveness ACCP/AACvPR9 Low evidence and weak recommendation (2C)
Reduced health care utilization ACCP/AACvPR9 Moderate evidence; weak recommendation (2B)
ACP clinical practice guideline37 PR programs reduce hospitalizations
Meta-analysis38 No material effect was observed on hospitalization rates
Meta-analysis,26 Cochrane review36 PR after acute COPD exacerbations reduced 
hospitalizations
GOLD3 PR reduced the number of hospitalizations and the  
number of days in hospital: evidence grade A‡
Improved survival ACCP/AACvPR9 Insufficient evidence and no recommendation provided
GOLD3 evidence grade B‡
ACP clinical practice guideline,37  
ACP systematic review,39 Meta-analysis38
No improvement in death
Notes: †Evidence comes from well-designed RCTs yielding consistent and directly applicable results: benefits clearly outweigh the risks and burdens; ‡GOLD RCTs: A = rich 
body of data; B = limited body of data.
Abbreviations: ACCP/AACVPR, American College of Chest Physicians/American Association of Cardiovascular and Pulmonary Rehabilitation; ACP, American College of 
Physicians; COPD, chronic obstructive pulmonary disease; GOLD, Global initiative for Obstructive Lung Disease; PR, pulmonary, rehabilitation; RCT, randomized controlled 
trial.
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patients are heavy users of health care resources. A large 
study examining health care utilization following a 6-week 
PR program found that, in comparison with a control group 
who received “usual care,” patients in the rehabilitation group 
had the same number of hospital admissions but spent less 
time in hospital (10 versus 21 days) during the 1-year follow 
up.40 A reduction of health care utilization with PR was also 
confirmed in another randomized, controlled trial (RCT) 
study with a follow up of 2 years41 and in nonrandomized 
clinical studies.42–44 Moreover, in two meta-analyses involving 
respectively 230 and 432 COPD patients, PR following the 
exacerbation of COPD significantly reduced hospital admis-
sion and mortality.26,36 Finally, Griffiths et al reported that 
PR was found to be cost effective and resulted in financial 
benefits.45 A more recent Canadian study suggested that PR 
is cost effective for patients with relatively high utilization 
of emergency and hospital-based services.46
Components in pulmonary  
rehabilitation
PR is a comprehensive, multidisciplinary (Figure 2), 
multicomponent, patient-centered intervention, consisting 
of a prerehabilitation assessment program, exercise and 
muscle training, self-management education, occupational 
therapy, psychosocial support, and nutritional intervention. 
Although most PR programs include these aspects, they may 
vary considerably from one center to another. Most programs 
involve 2 to 3 hours of education and exercise, three times 
weekly for at least 6 weeks. Figure 3 summarizes the steps 
and benefits of PR.
Setting and length for pulmonary 
rehabilitation programs
The structure and the setting of PR vary widely around 
the world. PR programs can be conducted with benefits in 
inpatient, hospital, or community-based outpatient or home-
based settings.8,47,48 However, most of the evidence for PR 
has been obtained from studies performed in a hospital-based 
outpatient setting.6,8,9 In the case of home-based PR, patients 
do not benefit from the group dynamics or from the same 
safety as can be found in the other modalities. Home-based 
PR remains limited to exercise training, without the numer-
ous benefits gained from a multidisciplinary team, and in 
addition, can be inferior in efficacy to the out- and inpatient 
supervised programs.8,49 Nevertheless, a recent study by 
Maltais et al boosted the interest in home-based PR as an 
alternative equivalent to hospital outpatient PR.48 Finally, 
the choice setting remains a question of patient motivation, 
disease severity and complex morbidities, local program 
availability, and available resources.
The minimum duration of an effective ambulatory PR 
program is currently unknown,9 but the GOLD guidelines 
suggest 6 weeks.3 It appears that a minimum of 20 sessions 
is needed to achieve physiological benefits,8,9 although longer 




















Figure 2 Multidisciplinary team involved in comprehensive pulmonary rehabilitation centered on the COPD patients.
Abbreviation: COPD, chronic obstructive pulmonary disease.
Symptomatic COPD patient
with limited physical and social activities




















Well-tailored, comprehensive pulmonary rehabilitation center environment
Figure 3 Summary of the steps and benefits of pulmonary rehabilitation.
Abbreviation: COPD, chronic obstructive pulmonary disease.
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programs are associated with better results.3,50,51 A recent 
review concluded that prolonged PR programs tend to have 
more favorable effects on HRQoL, but the results for exercise 
capacity are less clear.52 Furthermore the limited number of 
RCTs comparing different lengths of PR prevents a more defin-
itive conclusion on the optimal duration of PR.52 Conversely, 
an interesting meta-analysis concluded that patients with mild 
or moderate COPD benefit from short- and long-term reha-
bilitation, whereas patients with severe COPD may benefit 
from rehabilitation programs of at least 6 months.53 On the 
other hand, inpatient PR programs have a shorter duration 
and may result in physical performance improvement within 
2 weeks47 but are generally more expensive.54 Inpatient PR 
can be particularly reserved for more disabled patients with 
severe comorbidities, patients with limited transportation 
to the outpatient setting, or patients residing in areas where 
outpatient PR program facilities are limited.8
Prerehabilitation assessment program
Assessment of the patient, prior to initiation of PR but also, 
during and at the end of PR, is an essential element in the 
practice of PR. It allows the patient to have an individually 
tailored treatment based on their needs and problems and for 
adaptation of the program of PR according to the progress 
obtained.8,10 This assessment is carried out under the direction 
of the pulmonary physician specialized in rehabilitation. The 
pulmonary physician leads and coordinates the multidisci-
plinary team and is responsible for the medical treatment and 
rehabilitation program and for investigating comorbidities 
that could contraindicate or interact with PR (as described 
previously).6,9,55 The possible assessments include past medi-
cal history (including comorbidities), physical examination, 
cycling cardiopulmonary exercises (incremental workload), 
the 6-minute walk test, the shuttle walking test, pulmonary 
function tests, maximal expiratory and inspiratory pres-
sure evaluations, measurement of peripheral muscle forces, 
disease-specific questionnaires, and nutritional and psycho-
logical evaluations.
exercise training
Continuous and interval training as well as strength training 
may be regarded as the major exercise components of PR.56
Continuous and interval training
Endurance training is the most common exercise modality 
in COPD patients. The main objective is to improve aero-
bic exercise capacity as aerobic activities are part of many 
tasks.56 The exercise training is guided by the following three 
parameters: intensity, frequency, and duration.9
Lower extremity exercise training at a higher exercise 
intensity produces greater physiologic benefits than does 
training at a lower intensity, in patients with COPD.9 
Nonetheless, both low-intensity and high-intensity exercise 
training produce clinical benefits for patients with COPD.9 
Indeed, muscular functional disorders are reversible with 
moderate- to high-intensity rehabilitation exercise,8,57,58 with 
the same magnitude changes across GOLD stages II to IV.59 
Low-intensity training results in improvements in symptoms, 
HRQoL, and some aspects of performance of the activities 
associated with daily living;8 moreover, the long-term adher-
ence seems to be better with low-intensity training. However, 
training programs should attempt to achieve maximal physi-
ologic effects.8 So high-intensity training is proposed in PR 
centers. High-intensity training targets have been defined to 
be at least 60% to 80% of the peak work rate achieved in an 
incremental maximal exercise test.9 This intensity seems suf-
ficient to elicit some physiologic training effects.8 The total 
effective training time should ideally be over 30 minutes.8 
Endurance exercise of the leg muscles is the main focus, with 
walking, stationary cycling, and treadmill exercise being 
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Duration of daily physical activity
(≥3 MET) (min/day)
Figure 4 Use of a multisensory accelerometer.
Notes: (A) An accelerometer worn on the arm. (B) Data recorded by the accelerometer from a severely disabled GOLD Iv COPD patient.
Abbreviations: MeT, metabolic equivalent; COPD, chronic obstructive pulmonary disease; GOLD, Global initiative for Obstructive Lung Disease; min/day, minutes per day.





commonly performed.55 In clinical practice, symptom scores 
can be used to adjust the training load (eg, a Borg score of 
4 to 6 for dyspnea).8,60
Most programs involve three sessions per week, of which 
a minimum of two sessions should be supervised,8 with a 
duration of at least 6−8 weeks.3,61
For severely breathless patients, it is not possible to 
achieve the above training targets. In such cases, an interval 
training regime may be preferred.55,62 Here, the continuous 
exercise session is substituted by a succession of shorter 
high-intensity exercise periods alternated with low- to 
moderate-intensity exercise recovery periods.62 This form 
of training may be more comfortable for patients with more 
severe dynamic hyperinflation,10 and adherence to the treat-
ment may be better.63 Patients with severe COPD may also 
increase the total exercise duration with lower metabolic and 
ventilatory stress.56
During the training sessions, oxygen saturation, heart rate, 
and blood pressure are measured. Supplementary oxygen is 
given in order to maintain an oxygen saturation of above 
90%.6,9,31 All the measured parameters are recorded in the 
medical file. As the rehabilitation program proceeds, thera-
pists should be encouraged to adjust the training intensity. 
Retesting may provide physiological evidence that a training 
response has occurred and may be useful in the adjustment 
of intensity levels during the program.64
Strength training
Strength training (resistance exercises) would be particularly 
indicated for patients with significant muscle atrophy and 
marked dyspnea on minimal exertion.8 For each patient, the 
physiotherapist chooses the optimal resistance, frequency of 
exercise, speed, and mode of training and also, the implemen-
tation during the PR program. The addition of the strength 
training component increases muscle mass and strength.9 The 
combination of endurance and strength training generally has 
multiple beneficial effects and is well tolerated.
Upper limb training
PR programs have traditionally focused on the lower extremi-
ties, but many patients report dyspnea during daily activities 
that involve use of their arms, such as dressing, washing, and 
carrying groceries. Accordingly, upper limb exercises should 
be incorporated into the training program,8 using an arm 
cycle ergometer, free weights, or elastic bands. All modes 
of arm exercise have been shown to increase arm endurance 
capacity by a clinically significant level compared with no 
arm training.65,66
Adjunct to the exercise training
Neuromuscular electrical stimulation
Neuromuscular electrical stimulation (NMES) may be 
an adjunctive therapy for patients with severe chronic 
respiratory diseases who are bedbound or suffering from 
extreme skeletal muscle weakness.9 NMES can be conducted 
at home and is safe and relatively inexpensive.10 NMES was 
shown to enhance walking performance in patients with 
severe COPD.67
Respiratory muscle training
Inspiratory muscle training (IMT) is not recommended as a 
routine component of a PR program9 but should be consid-
ered in COPD patients with ventilatory muscle weakness.8 
Normocapnic hyperpnea resistive training and threshold 
loading have been described as training modalities.8 The use 
of a threshold loading device can be recommended for train-
ing the inspiratory muscles.37,68 Moreover, a meta-analysis 
of 25 studies that assessed the efficacy of IMT in patients 
with stable COPD found significant increases in inspiratory 
muscle strength, exercise capacity, and one measure of qual-
ity of life, and a significant decrease in dyspnea.69
Alternative treatment
Beyond the classical modes of training, such as walking, 
cycling, stepping, and arm training, there have been a 
few recently published papers on the effects of alternative 
exercise training modalities, in people with COPD. Among 
these, we have found two alternative modes − water-based 
rehabilitation (in patients with physical comorbidities, 
including musculoskeletal, peripheral vascular disease, and 
neurological conditions or obesity)70 and Tai Chi − that seem 
to be well tolerated and enjoyed by patients.71,72
education
Patient education, incorporating self-management training, 
remains an important component of any comprehensive PR 
program, despite the difficulties in measuring its direct con-
tribution to overall outcome.8,9 The content of the education 
program varies depending on local resources, but the topics 
commonly covered are aspects of the disease, physiotherapy 
skills, nutrition interventions, energy conservation, and 
psychosocial interventions.
Disease education
All patients should receive disease education to improve their 
compliance with medication regimens,10 oxygen therapy, 
smoking cessation, nutritional interventions, exercise, and 
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health preservation, all of which contribute to the overall 
autonomy of the patient. Patient education includes relevant 
topics associated with COPD (eg, anatomy, pathophysiology, 
nutritional advice, disease education, breathing techniques 
and pharmacology, oxygen therapy, smoking cessation, 
inhalation techniques, symptom management, chest clearance 
techniques, energy conservation, daily exercise, psycho-
logical interventions, anxiety management, relaxation, goal 
setting, travelling with COPD, sexuality issues, prevention 
and early recognition/management of COPD exacerbation, 
end of life issues, etc). Patient education aims to equip the 
patient with the knowledge and skills they need to manage 
their disease and to change their lifestyle, which is the ulti-
mate aim of PR. All the multidisciplinary team members 
participate in educational programs.
Physiotherapy skills
Chest physiotherapy represents a nonessential component of 
PR but proves its usefulness in patients with a marked bron-
chial hypersecretion.55 Relaxation exercises, flexibility and 
stretching exercises, breathing techniques (eg, pursed lip and 
diaphragmatic breathing) are often coupled with an exercise 
training session.35,73 These are administered for a brief period 
(5−10 minutes) and are recommended to maintain muscle 
length and to prevent injury and soreness.
energy conservation
Occupational therapists contribute to the evaluation of 
a patient’s autonomy and may recommend technical 
support and energy conservation techniques, depend-
ing on the type of disability. They also educate the 
oxygen-dependent patient.
Nutritional intervention
In COPD, nutritional depletion is common and has a negative 
impact on respiratory as well as on skeletal muscle functions, 
and contributes to the morbidity and mortality of COPD 
patients.74 Achievement of optimal nutritional status should 
help to maximize the patient’s state of health, respiratory 
muscle function, and overall sense of wellbeing.55 The dieti-
cian’s role is to establish a dietary history, evaluate the body 
mass index (BMI), measure the body fat percentage (eg, by 
impedancemetry), and ensure dietary follow up. Underweight 
patients may require nutritional advice (caloric supplements 
may be required) prior to commencing a PR program to 
ensure that the extra physical activity does not lead to further 
weight loss. Overweight patients may also need nutritional 
advice regarding weight loss, but the challenge here, is to 
not lose fat-free mass.10 Current scientific evidence does not 
support the routine use of anabolic agents in PR for patients 
with COPD.9
Psychosocial support
Anxiety and depression are important comorbidities 
of COPD,3,12,13,75 and a significant proportion of COPD 
patients referred to PR centers suffer from these psychiatric 
disorders.13,75 The psychologist can be helped to evaluate for 
anxiety−depression disorders by means of tools such as the 
Hospital Anxiety and Depression Scale (HADS), as symp-
toms of anxiety in COPD have been demonstrated to have a 
negative impact on quality of life (QoL).76
QoL can be assessed with a disease-specific question-
naire, such as the Chronic Respiratory Disease Question-
naire (CRQ)77 or the St George’s Respiratory Questionnaire 
(SGRQ).78,79 The psychosocial interventions for patients 
include disability evaluation, vocational counseling, and 
continued education of patient and family. In addition, 
psychological support can facilitate the adjustment process 
by encouraging adaptive thoughts and behavior − coping 
strategies that help patients to reduce their negative emo-
tions, which in turn, may improve compliance with PR. 
Psychological support helps in overcoming addictions, 
especially tobacco smoking and, along with medical treat-
ment for smoking cessation, is an important intervention 
in PR programs.10 In some instances, the social worker 
provides assistance to the patient in securing financial 
support.
Maintenance program
The benefits of a PR program tend to diminish over the months 
following its discontinuation. PR programs are usually not 
associated with sustained benefits beyond 12 months.40,43,80,81 
However, programs lasting for at least 6 months have been 
more successful in maintaining outcomes, even in the absence 
of structured maintenance programs.41,82 Maintenance of 
the benefits of PR – such as physical activity and lifestyle 
changes – is an important challenge for those who have 
undergone a comprehensive PR program.
Many centers currently offer maintenance programs in 
the hope of consolidating and prolonging the benefits of a 
successful rehabilitation program. However, the optimal 
strategy to meet this aim has not yet been described. Among 
the available options, we find telephone contacts and monthly 
supervised reinforcement sessions,83,84 home exercise training 
(with or without a weekly supervised outpatient session),85 
and recurrent PR programs.86,87





A systematic review concluded that after 8 weeks of 
supervised physical exercise training, maintenance programs 
consisting of weekly telephone calls and monthly reinforce-
ment sessions for 1 year were unsuccessful in altering behav-
ior and maintaining the treatment effects.35 Moreover a recent 
meta-analysis has suggested that post-PR exercise programs 
for COPD patients are superior to traditional care in main-
taining exercise capacity in the medium term (6 months) but 
not in the long term ($1 year) and have no sustained effect 
at all with regard to the HRQoL.88 These results should be 
interpreted with caution, given the heterogeneity in interven-
tions, follow-up intervals, and outcomes measures.
The best and the most effective maintenance program 
currently remains to be found. Beyond post-PR exercise 
programs, the PR center staff, as well as family members 
and general practitioners, should encourage and motivate the 
patient to follow the maintenance program and continue with a 
more active lifestyle, in order to retain the gains. This advice is 
supported by the 12-month follow-up data taken from a cohort 
of COPD patients who had completed a 10-week comprehen-
sive PR program and who were invited to follow a structured 
home program at the end of the PR program.89 At the 1-year 
follow-up evaluation, only the patients who had continued 
with the “prescribed” exercise routine had maintained the 
gains achieved in physical endurance, and psychological and 
cognitive functioning during the initial intervention.
Pulmonary rehabilitation  
and effect on physical activity
Patients with COPD are typically less active in daily life than 
are healthy older adults.90 In addition, inactivity is associ-
ated with poor functional status and higher risk of hospital 
admissions and mortality.91 It appears obvious that COPD 
patients would be more physically and socially active after 
PR. However, there is currently no strong evidence that 
patients translate the benefits obtained from PR into a more 
active lifestyle in real life.
Cindy et al92 recently published the first meta-analysis 
evaluating the effect of exercise training on measures 
of physical activity. This meta-analysis pointed out that 
supervised exercise training confers a significant but small 
effect on physical activity. The principal limitation of the 
meta-analysis was that the majority of the included studies 
did not use the same method to measure physical activ-
ity; moreover, it is well known that questionnaires and 
pedometers are an insufficiently sensitive means of detect-
ing changes in physical activity in this particular clinical 
(slow-walking) population.90,93,94 When the authors considered 
only those studies that utilized a multisensory accelerometer 
to measure physical activity, they obtained more significant 
improvements in physical activity.92 Accelerometers or activ-
ity monitors are small devices carried on the arm, leg, or 
waist that measure energy expenditure, movement pattern, 
and body position over a period of time (24 hours to 7 days) 
and provide objective measurements of daily life activity 
(Figure 4). Two parameters appear to be crucial to enhancing 
physical activity in COPD patients after PR: the frequency of 
supervised exercise training and the duration of the program. 
Indeed, in the meta-analysis by Cindy et al,92 the studies 
that proposed an exercise training regimen of three times 
per week showed a significant increase in physical activity, 
in contrast with those that offered exercise only two times 
a week. Moreover, in a study measuring physical activity 
with an accelerometer, Pitta et al93 showed that a 6-month, 
supervised exercise training program was required to obtain 
a significant effect on physical activity, while three months 
was shown to be insufficient. This is consistent with the 
recent concept that 6 months are needed for most people 
to change behavior.95 The recording of spontaneous daily 
physical activity provides a new dimension in patient assess-
ment that goes beyond any measurement of physiological 
capacity. Daily activity and the completion of domestic tasks 
are more important for the patient than an improvement in 
the 6-minute walk test, total CRQ score, or maximal load 
achieved during ergospirometry. Thus clinicians should take 
into account what people actually do (eg, walking, climbing 
stairs, dressing, etc), rather than what they are capable of 
doing since it is the natural level of physical activity that 
seems to best determine the prognostic benefit.96
As mentioned above, a study showed that a better outcome 
of PR can be obtained by its association with long-acting 
anticholinergic bronchodilators.5 This treatment appears to 
amplify the effectiveness of PR, as seen by greater improve-
ments (beyond that obtained with PR alone) in patient self-
reported participation in physical activities outside of the 
PR program, during the 8 weeks of PR and the 12 weeks 
following.97
Finally, new studies using accelerometers are needed 
to validate their use98 and to go further in this crucial 
domain linking PR and physical activity, since we know 
that physical activity levels determine the survival in 
COPD patients.
Conclusion
Tailored pulmonary rehabilitation programs should be con-
sidered for COPD patients of all stages, who have respiratory 
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symptoms and/or who have intolerance to physical effort 
despite optimal pharmacological treatment.
PR has certainly been demonstrated to provide beneficial 
effects on dyspnea, improvement in muscle strength and 
endurance, improvement of psychological status, reduction of 
hospital admissions, and improvement of HRQoL in COPD 
patients, with a gradual increase in daily physical activity 
and autonomy.
Successful PR therefore requires behavioral changes. To 
achieve this, patients’ skill and adherence may be facilitated 
if they are enrolled in longer, comprehensive programs 
comprising interactions with a multidisciplinary team offer-
ing support, council, encouragement, and coaching. These 
changes rest on the following: exercise training; psychosocial 
support; nutritional intervention; self-management; and 
education, as well as pacing and energy conservation strate-
gies, all of which are intended for motivated COPD patients. 
Therefore, PR embodies a very important and safe therapeutic 
option that aims to reverse the systemic manifestations of 
COPD and which, along with pharmacological therapy, can 
be used to obtain optimal patient management, leading to 
a favorable change in the daily life of our COPD patients. 
Accordingly, with the increasing burden of COPD patients 
in the world, there is an urgent need for advocacy with the 
concerned authorities, for a more widespread reimbursement 
of PR programs worldwide.
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